Loading…

Inactivation of Smad4 in gastric carcinomas

Allelic loss of chromosome 18q has been noted in intestinal type gastric adenocarcinomas. Smad4 is a gene located at 18q that was recently cloned in humans and found to be significantly altered in pancreatic cancers. We sought to determine whether Smad4 genetic alterations played a significant role...

Full description

Saved in:
Bibliographic Details
Published in:Cancer research (Chicago, Ill.) Ill.), 1997-10, Vol.57 (19), p.4221-4224
Main Authors: POWELL, S. M, HARPER, J. C, HAMILTON, S. R, ROBINSON, C. R, CUMMINGS, O. W
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 4224
container_issue 19
container_start_page 4221
container_title Cancer research (Chicago, Ill.)
container_volume 57
creator POWELL, S. M
HARPER, J. C
HAMILTON, S. R
ROBINSON, C. R
CUMMINGS, O. W
description Allelic loss of chromosome 18q has been noted in intestinal type gastric adenocarcinomas. Smad4 is a gene located at 18q that was recently cloned in humans and found to be significantly altered in pancreatic cancers. We sought to determine whether Smad4 genetic alterations played a significant role in gastric tumorigenesis by studying 35 gastric adenocarcinomas of all histopathological types and pathological stages. Microdissected specimens were used for mutational analysis of Smad4 at the nucleotide level, including the entire coding region and intron/exon boundaries. Allelic imbalance was also analyzed at the Smad4 locus using two nearby microsatellite markers. One case of apparent biallelic inactivation of Smad4 was found in our study of 35 gastric carcinomas. A nonsense point mutation at codon 334 was demonstrated, which, similar to other Smad4 mutations, is predicted to truncate the conserved COOH-terminal domain of this protein. This Smad4 C to T transition mutation was proven to be somatically acquired. Allelic loss was also noted on chromosome 18q at a marker near Smad4 in this mutated gastric cancer, apparently producing complete inactivation of Smad4 in this tumor. Significant 18q allelic loss (56% of 34 informative cases) was noted in our gastric carcinomas using microsatellite markers near the Smad4 locus, regardless of histological subtype or pathological stage. Additionally, three cases of microsatellite instability were observed. Thus, Smad4 inactivation was noted in our gastric carcinomas; however, this event was rare. The frequent loss of chromosomal arm 18q observed in gastric cancers suggests the presence of other tumor suppressor genes in this region that are involved in gastric tumorigenesis. Further studies are needed to identify these other targets of inactivation during gastric cancer development.
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_79326430</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79326430</sourcerecordid><originalsourceid>FETCH-LOGICAL-h269t-c26a0999c0cb4c00e90ef0848744217274f5900e92ed82715eebff238e4bd6e63</originalsourceid><addsrcrecordid>eNo9j01LxDAQhoMo67r6E4QexIsUJl9NcpTFj4UFD-q5TNNEI226Jq3gv7di8TS88zwM8x6RNZVcl0oIeUzWAKBLKRQ7JWc5f8xRUpArsjKcU9CwJje7iHYMXziGIRaDL557bEURYvGGeUzBFhaTDXHoMZ-TE49ddhfL3JDX-7uX7WO5f3rYbW_35TurzFhaViEYYyzYRlgAZ8B50ELPTzGqmBJemt81c61mikrnGu8Z1040beUqviHXf3cPaficXB7rPmTrug6jG6ZcK8NZJTjM4uUiTk3v2vqQQo_pu17azfxq4Zgtdj5htCH_a0wLTpnhPx_XVug</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79326430</pqid></control><display><type>article</type><title>Inactivation of Smad4 in gastric carcinomas</title><source>Free E-Journal (出版社公開部分のみ)</source><creator>POWELL, S. M ; HARPER, J. C ; HAMILTON, S. R ; ROBINSON, C. R ; CUMMINGS, O. W</creator><creatorcontrib>POWELL, S. M ; HARPER, J. C ; HAMILTON, S. R ; ROBINSON, C. R ; CUMMINGS, O. W</creatorcontrib><description>Allelic loss of chromosome 18q has been noted in intestinal type gastric adenocarcinomas. Smad4 is a gene located at 18q that was recently cloned in humans and found to be significantly altered in pancreatic cancers. We sought to determine whether Smad4 genetic alterations played a significant role in gastric tumorigenesis by studying 35 gastric adenocarcinomas of all histopathological types and pathological stages. Microdissected specimens were used for mutational analysis of Smad4 at the nucleotide level, including the entire coding region and intron/exon boundaries. Allelic imbalance was also analyzed at the Smad4 locus using two nearby microsatellite markers. One case of apparent biallelic inactivation of Smad4 was found in our study of 35 gastric carcinomas. A nonsense point mutation at codon 334 was demonstrated, which, similar to other Smad4 mutations, is predicted to truncate the conserved COOH-terminal domain of this protein. This Smad4 C to T transition mutation was proven to be somatically acquired. Allelic loss was also noted on chromosome 18q at a marker near Smad4 in this mutated gastric cancer, apparently producing complete inactivation of Smad4 in this tumor. Significant 18q allelic loss (56% of 34 informative cases) was noted in our gastric carcinomas using microsatellite markers near the Smad4 locus, regardless of histological subtype or pathological stage. Additionally, three cases of microsatellite instability were observed. Thus, Smad4 inactivation was noted in our gastric carcinomas; however, this event was rare. The frequent loss of chromosomal arm 18q observed in gastric cancers suggests the presence of other tumor suppressor genes in this region that are involved in gastric tumorigenesis. Further studies are needed to identify these other targets of inactivation during gastric cancer development.</description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>PMID: 9331080</identifier><identifier>CODEN: CNREA8</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Adenocarcinoma - genetics ; Alleles ; Biological and medical sciences ; Chromosomes, Human, Pair 18 - genetics ; DNA-Binding Proteins ; Gastroenterology. Liver. Pancreas. Abdomen ; Humans ; Loss of Heterozygosity ; Medical sciences ; Microsatellite Repeats ; Smad4 Protein ; Stomach Neoplasms - genetics ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus ; Trans-Activators - deficiency ; Trans-Activators - genetics ; Tumors</subject><ispartof>Cancer research (Chicago, Ill.), 1997-10, Vol.57 (19), p.4221-4224</ispartof><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2843129$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9331080$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>POWELL, S. M</creatorcontrib><creatorcontrib>HARPER, J. C</creatorcontrib><creatorcontrib>HAMILTON, S. R</creatorcontrib><creatorcontrib>ROBINSON, C. R</creatorcontrib><creatorcontrib>CUMMINGS, O. W</creatorcontrib><title>Inactivation of Smad4 in gastric carcinomas</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>Allelic loss of chromosome 18q has been noted in intestinal type gastric adenocarcinomas. Smad4 is a gene located at 18q that was recently cloned in humans and found to be significantly altered in pancreatic cancers. We sought to determine whether Smad4 genetic alterations played a significant role in gastric tumorigenesis by studying 35 gastric adenocarcinomas of all histopathological types and pathological stages. Microdissected specimens were used for mutational analysis of Smad4 at the nucleotide level, including the entire coding region and intron/exon boundaries. Allelic imbalance was also analyzed at the Smad4 locus using two nearby microsatellite markers. One case of apparent biallelic inactivation of Smad4 was found in our study of 35 gastric carcinomas. A nonsense point mutation at codon 334 was demonstrated, which, similar to other Smad4 mutations, is predicted to truncate the conserved COOH-terminal domain of this protein. This Smad4 C to T transition mutation was proven to be somatically acquired. Allelic loss was also noted on chromosome 18q at a marker near Smad4 in this mutated gastric cancer, apparently producing complete inactivation of Smad4 in this tumor. Significant 18q allelic loss (56% of 34 informative cases) was noted in our gastric carcinomas using microsatellite markers near the Smad4 locus, regardless of histological subtype or pathological stage. Additionally, three cases of microsatellite instability were observed. Thus, Smad4 inactivation was noted in our gastric carcinomas; however, this event was rare. The frequent loss of chromosomal arm 18q observed in gastric cancers suggests the presence of other tumor suppressor genes in this region that are involved in gastric tumorigenesis. Further studies are needed to identify these other targets of inactivation during gastric cancer development.</description><subject>Adenocarcinoma - genetics</subject><subject>Alleles</subject><subject>Biological and medical sciences</subject><subject>Chromosomes, Human, Pair 18 - genetics</subject><subject>DNA-Binding Proteins</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Humans</subject><subject>Loss of Heterozygosity</subject><subject>Medical sciences</subject><subject>Microsatellite Repeats</subject><subject>Smad4 Protein</subject><subject>Stomach Neoplasms - genetics</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><subject>Trans-Activators - deficiency</subject><subject>Trans-Activators - genetics</subject><subject>Tumors</subject><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNo9j01LxDAQhoMo67r6E4QexIsUJl9NcpTFj4UFD-q5TNNEI226Jq3gv7di8TS88zwM8x6RNZVcl0oIeUzWAKBLKRQ7JWc5f8xRUpArsjKcU9CwJje7iHYMXziGIRaDL557bEURYvGGeUzBFhaTDXHoMZ-TE49ddhfL3JDX-7uX7WO5f3rYbW_35TurzFhaViEYYyzYRlgAZ8B50ELPTzGqmBJemt81c61mikrnGu8Z1040beUqviHXf3cPaficXB7rPmTrug6jG6ZcK8NZJTjM4uUiTk3v2vqQQo_pu17azfxq4Zgtdj5htCH_a0wLTpnhPx_XVug</recordid><startdate>19971001</startdate><enddate>19971001</enddate><creator>POWELL, S. M</creator><creator>HARPER, J. C</creator><creator>HAMILTON, S. R</creator><creator>ROBINSON, C. R</creator><creator>CUMMINGS, O. W</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19971001</creationdate><title>Inactivation of Smad4 in gastric carcinomas</title><author>POWELL, S. M ; HARPER, J. C ; HAMILTON, S. R ; ROBINSON, C. R ; CUMMINGS, O. W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h269t-c26a0999c0cb4c00e90ef0848744217274f5900e92ed82715eebff238e4bd6e63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Adenocarcinoma - genetics</topic><topic>Alleles</topic><topic>Biological and medical sciences</topic><topic>Chromosomes, Human, Pair 18 - genetics</topic><topic>DNA-Binding Proteins</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Humans</topic><topic>Loss of Heterozygosity</topic><topic>Medical sciences</topic><topic>Microsatellite Repeats</topic><topic>Smad4 Protein</topic><topic>Stomach Neoplasms - genetics</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><topic>Trans-Activators - deficiency</topic><topic>Trans-Activators - genetics</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>POWELL, S. M</creatorcontrib><creatorcontrib>HARPER, J. C</creatorcontrib><creatorcontrib>HAMILTON, S. R</creatorcontrib><creatorcontrib>ROBINSON, C. R</creatorcontrib><creatorcontrib>CUMMINGS, O. W</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>POWELL, S. M</au><au>HARPER, J. C</au><au>HAMILTON, S. R</au><au>ROBINSON, C. R</au><au>CUMMINGS, O. W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inactivation of Smad4 in gastric carcinomas</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>1997-10-01</date><risdate>1997</risdate><volume>57</volume><issue>19</issue><spage>4221</spage><epage>4224</epage><pages>4221-4224</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><coden>CNREA8</coden><abstract>Allelic loss of chromosome 18q has been noted in intestinal type gastric adenocarcinomas. Smad4 is a gene located at 18q that was recently cloned in humans and found to be significantly altered in pancreatic cancers. We sought to determine whether Smad4 genetic alterations played a significant role in gastric tumorigenesis by studying 35 gastric adenocarcinomas of all histopathological types and pathological stages. Microdissected specimens were used for mutational analysis of Smad4 at the nucleotide level, including the entire coding region and intron/exon boundaries. Allelic imbalance was also analyzed at the Smad4 locus using two nearby microsatellite markers. One case of apparent biallelic inactivation of Smad4 was found in our study of 35 gastric carcinomas. A nonsense point mutation at codon 334 was demonstrated, which, similar to other Smad4 mutations, is predicted to truncate the conserved COOH-terminal domain of this protein. This Smad4 C to T transition mutation was proven to be somatically acquired. Allelic loss was also noted on chromosome 18q at a marker near Smad4 in this mutated gastric cancer, apparently producing complete inactivation of Smad4 in this tumor. Significant 18q allelic loss (56% of 34 informative cases) was noted in our gastric carcinomas using microsatellite markers near the Smad4 locus, regardless of histological subtype or pathological stage. Additionally, three cases of microsatellite instability were observed. Thus, Smad4 inactivation was noted in our gastric carcinomas; however, this event was rare. The frequent loss of chromosomal arm 18q observed in gastric cancers suggests the presence of other tumor suppressor genes in this region that are involved in gastric tumorigenesis. Further studies are needed to identify these other targets of inactivation during gastric cancer development.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>9331080</pmid><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0008-5472
ispartof Cancer research (Chicago, Ill.), 1997-10, Vol.57 (19), p.4221-4224
issn 0008-5472
1538-7445
language eng
recordid cdi_proquest_miscellaneous_79326430
source Free E-Journal (出版社公開部分のみ)
subjects Adenocarcinoma - genetics
Alleles
Biological and medical sciences
Chromosomes, Human, Pair 18 - genetics
DNA-Binding Proteins
Gastroenterology. Liver. Pancreas. Abdomen
Humans
Loss of Heterozygosity
Medical sciences
Microsatellite Repeats
Smad4 Protein
Stomach Neoplasms - genetics
Stomach. Duodenum. Small intestine. Colon. Rectum. Anus
Trans-Activators - deficiency
Trans-Activators - genetics
Tumors
title Inactivation of Smad4 in gastric carcinomas
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T01%3A16%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inactivation%20of%20Smad4%20in%20gastric%20carcinomas&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=POWELL,%20S.%20M&rft.date=1997-10-01&rft.volume=57&rft.issue=19&rft.spage=4221&rft.epage=4224&rft.pages=4221-4224&rft.issn=0008-5472&rft.eissn=1538-7445&rft.coden=CNREA8&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E79326430%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-h269t-c26a0999c0cb4c00e90ef0848744217274f5900e92ed82715eebff238e4bd6e63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=79326430&rft_id=info:pmid/9331080&rfr_iscdi=true